Suppr超能文献

钠和肾素在肾脏疾病高血压中的相对作用。基于对呋塞米和普萘洛尔反应的评估。

The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.

作者信息

Wilkinson R, Sellars L, Pickering M, Robson V, Kerr D N

出版信息

Clin Nephrol. 1981 Dec;16(6):307-13.

PMID:7032775
Abstract

Twenty-seven patients with hypertension and varying degrees of renal failure were studied before and during the administration of frusemide. In 15 patients studies were repeated following the addition of propranolol. Mean exchangeable sodium was increased before the introduction of frusemide or propranolol in patients with azotemia, possibly due in part to the administration of other antihypertensive drugs, and was reduced to normal during frusemide treatment increasing slightly but significantly following the addition of propranolol. Blood pressure fell significantly with frusemide but there was no further significant fall with propranolol. The relationship of change in blood pressure to change in exchangeable sodium with frusemide did not reach significance. There was no relationship between changes in blood pressure and changes in plasma renin activity with frusemide, suggesting that the blood pressure response to frusemide is not limited by the rise in renin. The fall in blood pressure following the addition of propranolol was proportional to the dose of the drug but inversely proportional to the change in renin suggesting that renin levels are to some extent determined by the blood pressure response to propranolol rather than themselves determining that response. Serum creatinine was significantly increased during treatment with frusemide probably due to a combination of the effects of sodium depletion and the natural progression of the underlying renal disease rather than to nephrotoxicity. The further slight increase in serum creatinine following the addition of propranolol is in keeping with the reported effect of this drug on renal blood flow and glomerular filtration rate in patients without renal disease.

摘要

对27例患有高血压和不同程度肾衰竭的患者在服用速尿之前及期间进行了研究。其中15例患者在加用普萘洛尔后重复进行了研究。氮质血症患者在引入速尿或普萘洛尔之前,可交换钠均值增加,这可能部分归因于其他抗高血压药物的使用,在速尿治疗期间可交换钠均值降至正常,加用普萘洛尔后略有但显著增加。速尿使血压显著下降,但普萘洛尔未使血压进一步显著下降。速尿引起的血压变化与可交换钠变化之间的关系未达到显著水平。速尿引起的血压变化与血浆肾素活性变化之间无相关性,这表明速尿对血压的反应不受肾素升高的限制。加用普萘洛尔后血压下降与药物剂量成正比,但与肾素变化成反比,这表明肾素水平在某种程度上是由普萘洛尔对血压的反应决定的,而不是由肾素自身决定该反应。速尿治疗期间血清肌酐显著升高,这可能是由于钠耗竭的影响和潜在肾脏疾病的自然进展共同作用,而非肾毒性所致。加用普萘洛尔后血清肌酐进一步轻微升高,这与该药物对无肾脏疾病患者肾血流量和肾小球滤过率的报道作用相符。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验